Area of research
Genetics · Hematology
Research interest
Research interests include Hemoglobinopathies and Related Disorders, Iron Metabolism and Disorders, Blood groups and transfusion, and Folate and B Vitamins Research.
Improving Health Care Transition for Young Patients With Sickle Cell Disease Through Quality Network
Rapid electrical impedance detection of sickle cell vaso-occlusion in microfluidic device
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis
Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease
Stroke and stroke prevention in sickle cell anemia in developed and selected developing countries
Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting
Electrical Impedance Characterization of Erythrocyte Response to Cyclic Hypoxia in Sickle Cell Disease
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis
Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)
Electrical impedance microflow cytometry with oxygen control for detection of sickle cells
Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non‐transfused cohorts
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial
Renal medullary carcinoma and sickle cell trait: A systematic review
Effects of hydroxyurea treatment for patients with hemoglobin <scp>SC</scp> disease
Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload
TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia
Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia
Sickle cell disease related mortality in the United States (1999-2009)
Pain and other non‐neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: Results from the SWiTCH clinical trial
Pain Assessment During a Vaso-Occlusive Crisis in the Pediatric and Adolescent Patient
Impact of hydroxyurea on clinical events in the BABY HUG trial
Effect of hydroxyurea treatment on renal function parameters: Results from the multi‐center placebo‐controlled BABY HUG clinical trial for infants with sickle cell anemia
Ventricular Structure and Function in Children With Sickle Cell Disease Using Conventional and Tissue Doppler Echocardiography
Durable immune response to inactivated H1N1 vaccine is less likely in children with sickle cell anemia receiving chronic transfusions